SCHEMBL13828232

SCHEMBL13828232

O=C(CS)NC[C@H]1CN(Cc2ccc(F)c(Cl)c2)CCO1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 15/20 0.56
CCR3 P51677 1/20 0.55
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C9 P11712 2/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADRA2B P18089 1/20 0.51
HTR2C P28335 1/20 0.51
SLC6A4 P31645 1/20 0.51
CYP2C19 P33261 1/20 0.51
DRD3 P35462 1/20 0.51
HTR2B P41595 1/20 0.51
KMT2A Q03164 1/20 0.51
KCNH2 Q12809 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
MCHR1 Q99705 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807501 0.91 DRD4 (0.57) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL1807499 0.91 DRD4 (0.57) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL12655639 0.91 CCR3 (0.65) DRD4CCR3CYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL1809649 0.90 DRD4 (0.56) DRD4CCR3CYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL1809651 0.90 DRD4 (0.56) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL1809601 0.83 DRD4 (0.54) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL1809602 0.83 DRD4 (0.54) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL4021624 0.83 CCR3 (0.59) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL4474137 0.82 DRD4 (0.55) DRD4CCR3CYP1A2CYP3A4CYP2C9
SCHEMBL6265631 0.82 DRD4 (0.55) DRD4CCR3CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1801108-B1 MORPHOLINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATIONS MITSUBISHI TANABE PHARMA CORP (JP) 2012-11-14 EP disclosed